About Us
About Gaea CRO
Gaea is a versatile, full-service, and digitally savvy CRO, and we emphasise agility, delivery, and quality.
We conduct clinical trials in the EU/EEA, Armenia, Georgia, the United Kingdom, Ukraine, and the USA; we have also partnered for infectious diseases in Bangladesh, such as with a dry powder nasal COVID-19 vaccine, and have a partner in West Africa.
From pharma consulting to global clinical trials CRO
Our journey from pharma consulting to a Contract Research Organisation (CRO) began in 2004, when a US biotech firm sought our assistance to overcome patient enrolment challenges in two Phase III clinical trials in haematology. These global trials, each spanning 45 sites across Europe, Israel, and Russia, presented a complex set of hurdles.
Poor site feasibility is common.
We discovered that even in 2004, the large CROs carried out inadequate feasibility studies. They had also introduced a process of site activation based on partial site readiness, leading to inevitable delays in actual screening.
This experience and other patient enrolment work with the same basic issues prompted the establishment of Gaea CRO UK in 2010. In 2018, Gaea was relocated to Estonia to remain within the EU, with clinical operations based in Ukraine due to the number of CROs and Pharma operating there before the 2022 war. Most of Gaea’s Clinical Operations team has relocated to Estonia, one of the world’s most digital nations.
Comprehensive clinical trial services
Gaea CRO offers in-house Data Management (DM) services and has contracted and qualified other service providers to offer clients a complete solution. This comprehensive approach allows us to meet our clients’ needs, ensuring a seamless and efficient clinical trial process.
Gaea CRO has made substantial and ongoing investments in a Quality Management System (QMS), Veeva Vault, and CRScube systems. We ensure rigorous computer system validation and data security through collaboration with a leading Estonian IT support company. Furthermore, our commitment to GDPR compliance is overseen by an experienced Data Protection Officer (DPO).
These investments testify to our unwavering commitment to the highest industry standards in quality and data security management.
Only experienced CRAs
We don’t have junior CRAs. Our nationally based Clinical Research Associates (CRA) team is very experienced. We stress the significance of such local expertise in managing trials, particularly in the complex disease areas in which we work. Gaea is dedicated to ensuring that the individuals involved in running trials possess the necessary experience to support site staff. Ongoing Gaea Trial Acceleration OÜ work confirms that weak feasibility and poor qualification processes create enrolment problems.
Drug indications and therapeutic areas
We manage trials for Investigational Medicinal Products (IMP) in various therapeutic areas, including:
- Significant respiratory diseases include Chronic Obstructive Pulmonary Disease (COPD) and Community-Acquired Pneumonia (CAP).
- Syndromes from serious unchecked inflammation, including acute respiratory distress syndrome, acute lung injury, sepsis, and shock. These trials are conducted in the intensive care setting.
- Multiple cancers, spanning from breast to prostate cancer.
Our expertise ensures comprehensive clinical trial management in these complex disease areas.
Medical device development and clinical investigations
In addition to our extensive experience in clinical trials for pharmaceuticals, we also work in the medical device sector. Currently, Gaea is leading the technical dossier preparation and clinical investigation for a Class 2b Investigational Medical Device targeting sepsis.
Gaea CRO
Full service
Comprehensive solutions with in-house Data Management and a focus on quality, data privacy, and cyber security, ensuring a seamless clinical trial process
Only experienced CRAs
Nationally based Clinical Research Associates (CRAs) with a proven track record of managing clinical trials in complex disease areas
Worldwide clinical trials
Clinical trials in the EU/EEA, Armenia, Georgia, the United Kingdom, Ukraine, and the USA; partnerships in Bangladesh and West Africa
Nigel Goodman
CEO at Gaea OÜ CRO and Clinical Trial Acceleration
I am passionate to bring products for significant diseases with unmet needs through trials in a fast effective way to quickly answer the clinical questions. I don’t believe using the largest CROs is always the cost-effective solution. The largest CROs must run a lot of trials to cover their cost base, though they take even the smallest trial these are small change. By necessity, risk-based monitoring becomes standard, face to face support to site staff is much reduced. Trials at sites are run by people, busy people, also managing patients in routine care.
In addition, my view is companies should all give back to the only world we live in – I choose to give back to sustainability here in Estonia, and education and conservation in Kenya.